Property:Query string
"Query string" is a predefined property that describes the conditions of the query as a string and is provided by Semantic MediaWiki. This property is pre-deployed (also known as special property) and comes with additional administrative privileges but can be used just like any other user-defined property.
K
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial +
[[:Publication: Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial]]
P
Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
[[Has subobject.Reference::Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer]]
V
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
[[:Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer]]
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
[[-Has subobject::Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer]] [[Drop-out::+]]
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
[[-Has subobject::Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer]] [[Outcome name::+]]
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
[[:Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer]]
L
Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study +
[[:Publication: Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study]]
P
[[Has subobject.Reference::Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients]]
N
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
[[:Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients]]
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
[[-Has subobject::Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients]] [[Drop-out::+]]
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
[[-Has subobject::Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients]] [[Outcome name::+]]
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
[[:Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients]]
P
Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
[[Has subobject.Reference::Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors]]
S
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
[[:Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors]]
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
[[-Has subobject::Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors]] [[Drop-out::+]]
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
[[-Has subobject::Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors]] [[Outcome name::+]]
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
[[:Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors]]
P
Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial +
[[Has subobject.Reference::Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial]]
R
Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial +
[[:Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial]]
Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial +
[[-Has subobject::Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial]] [[Drop-out::+]]